• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza va

tetano

Editor, Senior Moderator
Vaccine. 2015 Dec 22. pii: S0264-410X(15)01835-6. doi: 10.1016/j.vaccine.2015.12.038. [Epub ahead of print]
[h=1]Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.[/h] Luo Z[SUP]1[/SUP], Ma L[SUP]2[/SUP], Zhang L[SUP]1[/SUP], Martin L[SUP]3[/SUP], Wan Z[SUP]4[/SUP], Warth S[SUP]3[/SUP], Kilby A[SUP]3[/SUP], Gao Y[SUP]5[/SUP], Bhargava P[SUP]6[/SUP], Li Z[SUP]7[/SUP], Wu H[SUP]7[/SUP], Meissner EG[SUP]3[/SUP], Li Z[SUP]1[/SUP], Kilby JM[SUP]3[/SUP], Liao G[SUP]8[/SUP], Jiang W[SUP]9[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] There is increasing recognition of the role of B cell dysfunction in HIV pathogenesis, but little is known about how these perturbations may influence responses to vaccinations.
[h=4]METHODS:[/h] Healthy controls (n=16) and antiretroviral therapy (ART)-treated aviremic HIV-infected subjects (n=26) receiving standard-of-care annual influenza vaccinations were enrolled in the present study. Total bacterial 16S rDNA levels were assessed by quantitative polymerase chain reactions in plasma. Serologic responses were characterized by ELISA, hemagglutination inhibition assay (HI), and microneutralization, and cell-mediated responses were assessed by ELISPOT (antigen-specific IgG+ antibody-secreting cells (ASCs)) and flow cytometry at pre-vaccination (D0), day 7-10 (D7) and day 14-21 (D14) post-vaccination.
[h=4]RESULTS:[/h] Decreased peripheral CD4+ T cell absolute counts and increased frequencies of cycling and apoptotic B cells were found at baseline in HIV-infected subjects relative to healthy controls. In healthy controls, post-vaccination neutralizing activities were related to the frequencies of vaccine-mediated apoptosis and cycling of B cells, but not to CD4+ T cell counts. In patients, both baseline and post-vaccination neutralizing activities were directly correlated with plasma level of bacterial 16S rDNA. However, overall vaccine responses including antibody titers and fold changes were comparable or greater in HIV-infected subjects relative to healthy controls.
[h=4]CONCLUSION:[/h] B cell function correlates with measures of recall humoral immunity in response to seasonal influenza vaccination in healthy controls but not in ART-treated patients.
Copyright ? 2015. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Antibody responses; B cells; HIV disease; Influenza vaccine

PMID: 26721328 [PubMed - as supplied by publisher]
 
Back
Top Bottom